175 related articles for article (PubMed ID: 28820362)
1. Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.
Hasegawa E; Sato H; Wada Y; Takai K; Wakamatsu A; Nozawa Y; Nakatsue T; Kuroda T; Suzuki Y; Nakano M; Narita I
Lupus; 2018 Mar; 27(3):417-427. PubMed ID: 28820362
[TBL] [Abstract][Full Text] [Related]
2. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
[TBL] [Abstract][Full Text] [Related]
4. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
5. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
7. [Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome].
Masaki Y; Kawabata H; Takai K; Tsukamoto N; Fujimoto S; Ishigaki Y; Kurose N; Kojima M; Nakamura S; Kinoshita T; Aoki S;
Rinsho Ketsueki; 2016; 57(10):2029-2037. PubMed ID: 27795511
[TBL] [Abstract][Full Text] [Related]
8. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
11. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
12. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
13. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
15. [Systemic lupus erythematosus with marked eosinophilia and clinical features mimicking TAFRO syndrome].
Tokunaga M; Yamada M; Yoshikawa S; Kondo A; Mishima M; Inoue S; Morita T; Tominaga N
Rinsho Ketsueki; 2018; 59(6):688-694. PubMed ID: 29973444
[TBL] [Abstract][Full Text] [Related]
16. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
[TBL] [Abstract][Full Text] [Related]
18. Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome.
Ito S; Uchida T; Itai H; Yamashiro A; Yamagata A; Matsubara H; Imakiire T; Shimazaki H; Kumagai H; Oshima N
Intern Med; 2018 Nov; 57(21):3129-3133. PubMed ID: 29877281
[TBL] [Abstract][Full Text] [Related]
19. Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.
Iizuka-Honma H; Takizawa H; Nitta H; Mitsumori T; Noguchi M
J Clin Exp Hematop; 2023; 63(1):32-36. PubMed ID: 36990774
[TBL] [Abstract][Full Text] [Related]
20. Severe systemic inflammation mimicking TAFRO syndrome following COVID-19.
Tane M; Kosako H; Hosoi H; Tabata K; Hiroi T; Osawa K; Iwamoto R; Murata S; Mushino T; Murata SI; Araki SI; Fujii T; Sonoki T
Int J Hematol; 2023 Sep; 118(3):374-380. PubMed ID: 37000328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
